170 filings
6-K
VALN
Valneva SE
5 Jun 24
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update
6:05am
6-K
VALN
Valneva SE
4 Jun 24
Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June
12:16pm
6-K
VALN
Valneva SE
3 Jun 24
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
12:25pm
6-K
VALN
Valneva SE
31 May 24
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine
12:23pm
6-K
VALN
Valneva SE
21 May 24
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer
3:20pm
6-K
VALN
Valneva SE
13 May 24
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine
6:05am
6-K
VALN
Valneva SE
7 May 24
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates
12:09pm
6-K
VALN
Valneva SE
26 Mar 24
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F
6:44am
20-F
2023 FY
VALN
Valneva SE
Annual report (foreign)
22 Mar 24
5:10pm
6-K
VALN
Valneva SE
20 Mar 24
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
12:52pm
6-K
VALN
Valneva SE
18 Mar 24
Valneva Announces Extension of the Interest-Only Period of Its Debt Facility with Deerfield and OrbiMed
6:44pm
6-K
VALN
Valneva SE
4 Mar 24
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
4:39pm
6-K
VALN
Valneva SE
29 Feb 24
Current report (foreign)
3:00pm
6-K
VALN
Valneva SE
15 Feb 24
Valneva Reports Full Year 2023 Revenue and Cash, Provides First 2024 Guidance
6:51am
SC 13G/A
Deep Track Capital, LP
14 Feb 24
Valneva SE / Deep Track Capital ownership change
8:59am
6-K
VALN
Valneva SE
5 Feb 24
Valneva Announces Sale of Priority Review Voucher for $103 Million
6:05am
6-K
VALN
Valneva SE
10 Jan 24
Current report (foreign)
12:42pm
6-K
VALN
Valneva SE
8 Jan 24
Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum
8:00am
6-K
VALN
Valneva SE
29 Dec 23
Valneva Provides Updated 2023 Financial Guidance
5:13pm
6-K
VALN
Valneva SE
21 Dec 23
Valneva Shareholders Approve EGM Resolutions Including the Transition to a Board of Directors
3:57pm